IL98887A0 - A method for producing a protein that is naturally gamma carboxylated - Google Patents

A method for producing a protein that is naturally gamma carboxylated

Info

Publication number
IL98887A0
IL98887A0 IL98887A IL9888791A IL98887A0 IL 98887 A0 IL98887 A0 IL 98887A0 IL 98887 A IL98887 A IL 98887A IL 9888791 A IL9888791 A IL 9888791A IL 98887 A0 IL98887 A0 IL 98887A0
Authority
IL
Israel
Prior art keywords
protein
producing
gamma carboxylated
naturally
naturally gamma
Prior art date
Application number
IL98887A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL98887A0 publication Critical patent/IL98887A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL98887A 1986-04-09 1991-07-18 A method for producing a protein that is naturally gamma carboxylated IL98887A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84999986A 1986-04-09 1986-04-09

Publications (1)

Publication Number Publication Date
IL98887A0 true IL98887A0 (en) 1992-07-15

Family

ID=25307027

Family Applications (5)

Application Number Title Priority Date Filing Date
IL98886A IL98886A (en) 1986-04-09 1987-04-02 Method for producing a functional polypeptide in a eukaryotic cell
IL98887A IL98887A (en) 1986-04-09 1987-04-02 Method for producing a protein that is naturally gamma carboxylated
IL82093A IL82093A (en) 1986-04-09 1987-04-02 Method of using eukaryotic expression vectors comprising the bk virus enhancer
IL98886A IL98886A0 (en) 1986-04-09 1991-07-18 Method for producing a functional polypeptide in a eukaryotic cell
IL98887A IL98887A0 (en) 1986-04-09 1991-07-18 A method for producing a protein that is naturally gamma carboxylated

Family Applications Before (4)

Application Number Title Priority Date Filing Date
IL98886A IL98886A (en) 1986-04-09 1987-04-02 Method for producing a functional polypeptide in a eukaryotic cell
IL98887A IL98887A (en) 1986-04-09 1987-04-02 Method for producing a protein that is naturally gamma carboxylated
IL82093A IL82093A (en) 1986-04-09 1987-04-02 Method of using eukaryotic expression vectors comprising the bk virus enhancer
IL98886A IL98886A0 (en) 1986-04-09 1991-07-18 Method for producing a functional polypeptide in a eukaryotic cell

Country Status (11)

Country Link
EP (3) EP0576049A1 (xx)
JP (5) JP3162056B2 (xx)
AU (1) AU605479B2 (xx)
CA (2) CA1340384C (xx)
DE (3) DE3752382T2 (xx)
DK (1) DK176387A (xx)
ES (3) ES2237755T3 (xx)
HK (2) HK1021861A1 (xx)
HU (1) HU211391B (xx)
IE (3) IE81065B1 (xx)
IL (5) IL98886A (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613481D0 (en) * 1986-06-04 1986-07-09 Diatech Ltd Translation of mrna
EP3020808B1 (en) * 2013-07-11 2019-09-11 Takara Bio Inc. Method for manufacturing adeno-associated virus
EP3105311A1 (en) 2014-02-10 2016-12-21 Univercells NV System, apparatus and method for biomolecules production
EP3168298B1 (en) 2014-07-10 2019-04-17 Takara Bio Inc. Production method for non-enveloped virus particles
CN107109374B (zh) 2015-01-09 2021-04-06 宝生物工程株式会社 用于生产无包膜病毒颗粒的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327860D0 (en) * 1983-10-18 1983-11-16 Fujisawa Pharmaceutical Co Monoclonal antiprotein c antibody
JPH0789930B2 (ja) * 1984-03-08 1995-10-04 大正製薬株式会社 ウイルス性転写促進配列
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
JPH02502605A (ja) * 1987-03-13 1990-08-23 シェリング・コーポレーション 遺伝子発現の刺激方法
JPH0660120A (ja) * 1992-08-06 1994-03-04 Sharp Corp 可変長データの格納方法及び検索装置

Also Published As

Publication number Publication date
DK176387D0 (da) 1987-04-07
IL82093A0 (en) 1987-10-30
EP0699764B1 (en) 2005-03-09
ES2237755T3 (es) 2005-08-01
IL98887A (en) 1992-12-01
HK1009605A1 (en) 1999-06-04
ES2107997T3 (es) 1997-12-16
JP3162056B2 (ja) 2001-04-25
AU605479B2 (en) 1991-01-17
EP0584845A1 (en) 1994-03-02
DK176387A (da) 1987-11-13
CA1318619C (en) 1993-06-01
IL82093A (en) 1992-12-01
HK1021861A1 (en) 2000-07-07
DE3752134T2 (de) 1998-03-19
DE3752382D1 (de) 2005-04-14
CA1340384C (fr) 1999-02-09
JP2877228B2 (ja) 1999-03-31
IE870912L (en) 1987-10-09
JPH099980A (ja) 1997-01-14
HUT43633A (en) 1987-11-30
IL98886A0 (en) 1992-07-15
JPS6312296A (ja) 1988-01-19
JPH1057081A (ja) 1998-03-03
DE3752382T2 (de) 2005-12-29
IE980257A1 (en) 1987-10-09
EP0699764A1 (en) 1996-03-06
EP0584845B1 (en) 2004-09-08
EP0576049A1 (en) 1993-12-29
ES2227514T3 (es) 2005-04-01
IE81065B1 (en) 2000-01-12
JPH11346789A (ja) 1999-12-21
AU7117587A (en) 1987-10-15
DE3752376D1 (de) 2004-10-14
JP2001145496A (ja) 2001-05-29
DE3752134D1 (de) 1997-12-04
JP2958286B2 (ja) 1999-10-06
IL98886A (en) 1992-12-01
HU211391B (en) 1995-11-28
IE980258A1 (en) 1987-10-09

Similar Documents

Publication Publication Date Title
GB2230618B (en) A method of forming a transmissive screen
GB2189367B (en) Method for producing a laser-printed picture
GB2188279B (en) Method of making a container
EP0270390A3 (en) A method for producing adiponitrile
GB2194232B (en) Method for producing a lactone
GB2194050B (en) A method of operating a seismic vibrator
EP0261333A3 (en) Method for producing a lining element and lining element thus produced
EP0205964A3 (en) Method for producing a silicone polymer-filler mixture
IL98887A0 (en) A method for producing a protein that is naturally gamma carboxylated
GB2189126B (en) A method of forming processed meat
GB2179003B (en) A method of producing a panel
DE3473180D1 (en) Method of producing a light-diffracting unit
EP0367733A3 (en) Method of making a carburetor
GB2197542B (en) Method of making a resistor
GB2189940B (en) Method of operating a multiple-electromagnet arrangement
GB2220946B (en) Method of producing free epsilon-polylysine
HK112194A (en) A method of making a rozor
PL278876A1 (en) Method of obtaining a mixture of ribonucleatides
GB2178428B (en) A method of producing paraquinones
GB2213900B (en) A method of making a frame
PL280010A1 (en) Method of obtaining a pseudopyrimicine complex
EP0326178A3 (en) Method of making a photosensor
GB2166844B (en) A method of loosening tightly-joined elements
ZA854921B (en) A method of separating heartbeat sources
PL262613A1 (en) A method of obtaining bisalkenylsuccinimides